Sodium-glucose co-transporter 2 (SGLT2) inhibitors

Sodium-glucose co-transporter 2 (SGLT2) inhibitors are medications used to lower blood sugar levels in people with type 2 diabetes. They work by blocking a protein in the kidneys called SGLT2, which normally reabsorbs glucose back into the blood. By inhibiting this protein, these drugs cause the excess glucose to be expelled through urine, reducing blood sugar levels. Additionally, SGLT2 inhibitors can help with weight loss and improve cardiovascular health. They are an important part of diabetes management, often used alongside other treatments, and have been shown to reduce the risk of certain complications associated with diabetes.